search for




 

Diabetic Papillopathy on Peripapillary Staphyloma in a 50-year-old Korean Patient
Journal of Retina 2018;3(2):88-91
Published online November 30, 2018
© 2018 The Korean Retina Society.

Hae Min Kang

Department of Ophthalmology, Catholic Kwandong University International St. Mary’s Hospital, Incheon, Korea
Correspondence to: Hae Min Kang, MD, PhD
Department of Ophthalmology, Catholic Kwandong University International St. Mary’s Hospital, #25 Simgok-ro 100beon-gil, Seo-gu, Inchoen 22711, Korea
Tel: 82-32-290-3888, Fax: 82-32-290-3879
E-mail: liebe05@naver.com
Received March 14, 2018; Revised June 1, 2018; Accepted June 25, 2018.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Purpose: We report a case of diabetic papillopathy in a patient with peripapillary staphyoma that was successfully treated via intravitreal dexamethasone implant injection.
Case summary: A 50-year-old male patient with peripapillary staphyloma exhibited diabetic papillopathy associated with subretinal fluid in the right eye. Intravitreal dexamethasone implant injection resolved both the diabetic papillopathy and subretinal fluid within 1 month, and yielded visual improvement.
Conclusions: Diabetic papillopathy can occur in a patient with peripapillary staphyloma. Intravitreal dexamethasone implants are viable treatment options for diabetic papillopathy.
Keywords : Dexamethasone implant; Diabetic papillopathy; Ozurdex; Peripapillary staphyloma


November 2018, 3 (2)
Full Text(PDF) Free

Social Network Service
Services

Cited By Articles
  • CrossRef (0)
  • CrossMark
  • Crossref TDM